Full-Time

Microbiology Supervisor

Microbiology

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

Albuquerque, NM, USA

In Person

Bachelor's

Category
Biology & Biotech
Required Skills
Microbiology

Get referred to Curia

See people who can refer or advise you

Requirements
  • Bachelor’s degree in a scientific discipline, preferably microbiology or related field
  • Minimum of three (3) years related work experience
  • Minimum of two (2) years in a leadership role
  • Experienced and proficient in the validation/qualification of lab microbiological techniques
  • Minimum of two (2) years industry experience in a GMP or GLP environment, preferred
  • Must pass a background check
  • Must pass a drug screen
  • May be required to pass Occupational Health Screening
  • May be required to obtain and maintain gowning certification
  • May be required to obtain and maintain media qualification
  • Working knowledge of GMPs/pharmaceutical environments is desirable
Responsibilities
  • Supervise daily operations of the microbiology laboratory, including scheduling, task assignments, and coordination of analysts and technicians.
  • Ensure completion of microbiological testing, environmental monitoring, and isolate identification in compliance with cGMP, regulatory standards, and company procedures.
  • Train, mentor, and qualify laboratory staff in microbiological test methods, equipment operation, and proper documentation practices; assist with onboarding of temporary personnel as needed.
  • Monitor laboratory equipment performance, troubleshoot technical issues, and escalate unresolved problems to the Microbiology Manager.
  • Oversee inventory of reagents, media, and test materials; ensure aseptic preparation, timely ordering, and accurate documentation.
  • Review and approve attendance records, vacation schedules, and other administrative requirements; implement corrective or disciplinary actions when necessary.
  • Prepare, revise, and maintain standard operating procedures (SOPs), protocols, and related documentation.
  • Coordinate specialized laboratory activities, including quarterly gamma sterilization dose audits, BI qualification, bioburden audits, and routine analyses (e.g., growth promotion, water testing, biennial biological indicators).
  • Perform and review cGMP documentation and calculations; prepare preliminary investigations and provide support for full investigations as required.
  • Support the Microbiology Manager during internal, customer, and regulatory audits; provide technical input and ensure laboratory readiness.
  • Partner with cross-functional groups, including R&D, Technical Services, and the Laboratory Systems Supervisor, to support laboratory initiatives and company projects.
  • Prepare study protocols, summary reports, and other documentation as requested by the Microbiology Manager or Associate Director, Laboratories.
  • Promote continuous improvement within the microbiology laboratory by identifying opportunities to streamline processes, improve efficiency, and uphold quality standards.
  • Perform other related duties as assigned.
  • Read/interpret SOPs to ensure compliance
  • Maintain up to date trainings
  • Other duties as assigned
Desired Qualifications
  • Minimum of two (2) years industry experience in a GMP or GLP environment, preferred
  • Previous experience with pharmaceutical cleanroom environments, preferred
  • Working knowledge of GMPs/pharmaceutical environments is desirable

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Albuquerque’s $200 million expansion adds commercial drug-product capacity during 2025-2026.
  • Glasgow’s upgrade reaches early 2027, expanding batches to 20,000 vials.
  • March 2025 refinancing and July 2026 recapitalization inject capital for near-term execution.

What critics are saying

  • Apollo-led recapitalization on July 8, 2026 signals strained leverage and lender control.
  • Curia will close Burlington by June 1, 2026, cutting 81 jobs and shrinking capacity.
  • Octus reported June 2, 2026 out-of-court restructuring talks; a failed process risks insolvency.

What makes Curia unique

  • Curia spans discovery through commercial fill-finish across 20+ sites, rare among CDMOs.
  • Glasgow and Albuquerque expansions deepen sterile injectables capacity, including Annex 1 isolator lines.
  • Hopkinton CLD upgrades deliver sixfold higher titers, strengthening biologics process-development economics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.